← All candidates
22 insider filings on record.
22 filings on record.
MRSNMersana Therapeutics, Inc.
—
22 insider filings on record.
None of them an open-market buy in the last year.
No price data yet — the yfinance scanner hasn't produced bars for MRSN.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Short % float
Pro
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
17 more transactions on Pro →Context
Coverage
How The Day One Deal Is Reshaping The Story For Mersana Therapeutics (MRSN)Simply Wall St. · 01-08Day One concludes Mersana Therapeutics acquisitionPharmaceutical Technology · 01-08Why Analysts See Mersana’s Story Shifting To Deal And CVR Outcomes After $1B BuyoutSimply Wall St. · 12-15How Mersana’s Acquisition Is Changing the Story and Analyst Outlook for InvestorsSimply Wall St. · 11-30
The file stays open
22 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice